Metaculus

Total Gene-Edited Human Births before 2030

Science

Deepmind Latest Ai Tool Makes Sense Changes Human Genom

The Wellcome Trust has provided £10 million ($13 million) in initial funding for the Synthetic Human Genome Project (SynHG), a five-year, multi-university project led by Cambridge University's MRC Laboratory of Molecular Biology, which attempts to create human DNA building blocks from scratch.

Wellcome

BBC News

The Wellcome Trust has provided £10 million ($13 million) in initial funding for the Synthetic Human Genome Project (SynHG), a five-year, multi-university project led by Cambridge University's MRC Laboratory of Molecular Biology, which attempts to create human DNA building blocks from scratch.

The project aims to develop foundational tools and methods for synthesizing large sections of human DNA, potentially creating an entire synthetic human chromosome representing approximately 2% of total human DNA. Unlike genome editing which modifies existing genes, genome synthesis allows for changes at greater scale and density with more accuracy and efficiency than current methods.</span

The project aims to develop foundational tools and methods for synthesizing large sections of human DNA, potentially creating an entire synthetic human chromosome representing approximately 2% of total human DNA. Unlike genome editing which modifies existing genes, genome synthesis allows for changes at greater scale and density with more accuracy and efficiency than current methods.

Researchers believe the technology could accelerate treatments for incurable diseases by generating disease-resistant cells to repopulate damaged organs in the liver, heart, and immune system. Dr. Julian Sale from Cambridge's MRC Laboratory stated the approach could lead to therapies improving aging and healthier lives with less disease as people get older.</span

WION

Researchers believe the technology could accelerate treatments for incurable diseases by generating disease-resistant cells to repopulate damaged organs in the liver, heart, and immune system. Dr. Julian Sale from Cambridge's MRC Laboratory stated the approach could lead to therapies improving aging and healthier lives with less disease as people get older.

Critics express concerns about potential misuse of the technology for creating biological weapons, enhanced humans, or designer babies. Dr. Pat Thomas from Beyond GM warned that while scientists aim to do good, the science could be repurposed for harm and warfare, with Professor Bill Earnshaw noting that restrictions may be ineffective against unscrupulous actors.</span

Critics express concerns about potential misuse of the technology for creating biological weapons, enhanced humans, or designer babies. Dr. Pat Thomas from Beyond GM warned that while scientists aim to do good, the science could be repurposed for harm and warfare, with Professor Bill Earnshaw noting that restrictions may be ineffective against unscrupulous actors.

A dedicated social science program led by Professor Joy Zhang at the University of Kent will run alongside the scientific development to address socio-ethical implications. The "Care-full Synthesis" initiative will conduct empirical studies with diverse global publics to promote accountable scientific practices and ensure robust social and legal deliberation accompanies the research.</span

Science Media Centre

A dedicated social science program led by Professor Joy Zhang at the University of Kent will run alongside the scientific development to address socio-ethical implications. The "Care-full Synthesis" initiative will conduct empirical studies with diverse global publics to promote accountable scientific practices and ensure robust social and legal deliberation accompanies the research.

Other synthetic biology companies are advancing DNA synthesis technologies, with Twist Bioscience using semiconductor miniaturization to produce genetic sequences 1,000 times more efficiently. LanzaTech focuses on carbon capture through synthetic biology, while Ginkgo Bioworks provides custom organism design services, and Codexis develops enzyme-driven biochemical processes for industrial applications.</span

Securities.io

Other synthetic biology companies are advancing DNA synthesis technologies, with Twist Bioscience using semiconductor miniaturization to produce genetic sequences 1,000 times more efficiently. LanzaTech focuses on carbon capture through synthetic biology, while Ginkgo Bioworks provides custom organism design services, and Codexis develops enzyme-driven biochemical processes for industrial applications.

Metaculus #0

Science #0

BBC News #

WION #

Science Media Centre #

Science #

The rush to create artificial human DNA opens dangerous doors that cannot be closed once opened, with no effective way to prevent bad actors from weaponizing this technology. The project essentially puts the building blocks of human life into a test tube, raising fundamental questions about who owns synthetic body parts and genetic data. Despite promises of medical benefits, the technology could lead to enhanced humans and biological weapons that threaten humanity's future.

The rush to create artificial human DNA opens dangerous doors that cannot be closed once opened, with no effective way to prevent bad actors from weaponizing this technology. The project essentially puts the building blocks of human life into a test tube, raising fundamental questions about who owns synthetic body parts and genetic data. Despite promises of medical benefits, the technology could lead to enhanced humans and biological weapons that threaten humanity's future.

Biological weapons? Concerns grow as scientists start working on creating artificial human DNA

Synthetic Human Genome Project gets go ahead

Wellcome Funds $13M Synthetic Human Genome Project

Research

Biology & biochemistry

Genetics & heredity

Ethics

This groundbreaking research represents the next logical step after genome sequencing and editing, offering unprecedented opportunities to understand human biology and develop life-saving treatments. The technology could revolutionize medicine by creating disease-resistant cells and organs, potentially solving problems that simple gene editing cannot address. With proper ethical oversight and public engagement built into the project from the start, the benefits far outweigh the risks.

This groundbreaking research represents the next logical step after genome sequencing and editing, offering unprecedented opportunities to understand human biology and develop life-saving treatments. The technology could revolutionize medicine by creating disease-resistant cells and organs, potentially solving problems that simple gene editing cannot address. With proper ethical oversight and public engagement built into the project from the start, the benefits far outweigh the risks.

Wellcome Funds $13M Synthetic Human Genome Project

Wellcome Funds $13M Synthetic Human Genome Project

The Spin

Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Wellcome Funds $13M Synthetic Human Genome Project

Wellcome Funds $13M Synthetic Human Genome Project

The Spin

Articles on this story

Sign Up for Our Free NewslettersSign Up for Our Free Newsletters

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters